Extranodal NK-T-cell lymphoma secondary prevention
|
Extranodal NK-T-cell lymphoma Microchapters |
|
Differentiating Extranodal NK-T-cell lymphoma from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Extranodal NK-T-cell lymphoma secondary prevention On the Web |
|
American Roentgen Ray Society Images of Extranodal NK-T-cell lymphoma secondary prevention |
|
Extranodal NK-T-cell lymphoma secondary prevention in the news |
|
Risk calculators and risk factors for Extranodal NK-T-cell lymphoma secondary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ramyar Ghandriz MD[2]
Overview
Effective measures for the secondary prevention of extranodal NK-T-cell lymphoma include: LDH , MLH1, PDGFRA, VEGF, PD-L1, PD-1, Cyclin D1, p53, Ki-67
Secondary Prevention
Effective measures for the secondary prevention of extranodal NK-T-cell lymphoma include:[1]
References
- ↑ Zeng, Linshu; Huang, Wenting; Cao, Zheng; Zheng, Bo; Liu, Xiuyun; Guo, Lei; Feng, Xiaoli (2019). "The correlation of clinicopathological features and prognosis in extranodal natural killer/T cell lymphoma: a report of 42 cases in the early stage". Annals of Hematology. 98 (6): 1467–1476. doi:10.1007/s00277-019-03643-9. ISSN 0939-5555.